AstraZeneca is discontinuing a late-stage drug trial in patients with metastatic non-small cell lung cancer, extending a run ...

Europe pulls Tavneos over trial integrity concerns, pricing concerns over AstraZeneca's hypertension drug, and more biotech ...

Over a dozen states now have laws enhancing their oversight of private equity deals in health care. A new report says that’s ...

The change in tone — from day to day and coast to coast — shows how Kennedy’s sprawling political messages tied to his Make ...

The Internal Revenue Service is investigating UnitedHealth Group, with an initial probe determining the health care ...

An executive order remaking the federal vaccine agenda, Epic's antitrust lawsuits, and more health news from Morning Rounds ...

Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...

Sanofi, one of the Massachusetts' largest pharmaceutical employers, will lay off more than 200 workers there a year after acquiring Blueprint Medicines.

Every August, Epic Systems founder Judy Faulkner holds court with over 20,000 people, including staff and executives from her most devoted customers, in an auditorium buried five stories into the ...

Casey’s reporting examines the use of artificial intelligence by providers and insurers. The Federal Trade Commission is examining Epic Systems Corp., the nation’s largest vendor of electronic health ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. A flurry of scientific gatherings and panels across federal science ...

Theresa is the lead Morning Rounds writer, and her stories focus on gender-affirming care, reproductive health, and mental health. You can reach Theresa on Signal at theresagaff.97. After the U.S.